US Patent Issued to Mangogen Pharma on June 2 for "Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals" (Canadian Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,831, issued on June 2, was assigned to Mangogen Pharma Inc. (Laval, Canada).

"Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals" was invented by Satya Prakash (Brossard, Canada), Arghya Paul (Longeuil, Canada) and Dominique Shum-Tim (Beaconsfield, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides viral microparticles comprising genetically-engineered baculoviruses (at least partially) embedded in a polymeric matrix for the local delivery of therapeutic nucleic acid molecules to the cells of a vertebrate individual (optionally in combination with a medi...